Condensed Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating activities
Net Income (Loss)	$ (1,579,820)	$ (2,243,070)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	254,029	284,572
Interest expense	124,658	123,288
Non-cash lease expense		37,676
Change in operating assets and liabilities:
Accounts receivable, net	(778,833)	(62,470)
Prepaid expenses and other current assets	222,045	281,568
Inventories	(106,936)	(75,489)
Accounts payable and accrued expenses	343,596	251,613
Accrued compensation	(1,058,129)	(190,907)
Operating lease liabilities		(37,676)
Net cash used in operating activities	(2,579,390)	(1,630,895)
Financing activities
Proceeds from February 2024 Offering, net of issuance costs	6,718,212
Payment of February 2024 Offering costs	(426,293)
Proceeds from amendment and exercise of Series B Warrants, net of issuance costs	1,250,800
Net cash provided by financing activities	7,542,719
Net increase (decrease) in cash and cash equivalents	4,963,329	(1,630,895)
Cash and cash equivalents at beginning of period	4,739,426	9,843,699
Cash and cash equivalents at end of period	9,702,755	$ 8,212,804
Supplemental disclosure of non-cash financing activities
Offering costs included in accounts payable	$ 20,926